Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
06/2005
06/23/2005CA2548899A1 Marine algae extract and lipase inhibitor containing the same
06/23/2005CA2547381A1 Marine algae extract and glycosidase inhibitor containing the same
06/22/2005EP1544299A1 Modified chimeric polypeptides with improved pharmacokinetic properties
06/22/2005EP1544295A1 Salt-inducible kinases 2 and use thereof
06/22/2005EP1544208A1 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
06/22/2005EP1544201A1 Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications
06/22/2005EP1544200A1 1,2,4 -TRIAZOLO 1,5-c PYRIMIDINE DERIVATIVE
06/22/2005EP1544199A1 Nitrogenous condensed-ring compound and use thereof as hiv integrase inhibitor
06/22/2005EP1544198A1 A process for the preparation of crystalline losartan potassium
06/22/2005EP1544194A1 4-(substituted aryl)-5-hydroxyisoquinolinone derivative
06/22/2005EP1543840A1 Drug absorbability improving agents
06/22/2005EP1543833A1 Phosphorylated dextran
06/22/2005EP1543830A1 Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides
06/22/2005EP1543824A2 Thiazole derivatives to counter advanced glycation
06/22/2005EP1543722A1 Nonhuman animal reproducing pathogenic conditions of spinal and bulbar muscular atrophy and remedy for spinal and bulbar muscular atrophy
06/22/2005EP1543325A2 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof
06/22/2005EP1543034A2 Treatment and prophylaxis with 4-1bb-binding agents
06/22/2005EP1543025A2 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure
06/22/2005EP1543024A2 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
06/22/2005EP1543011A2 Thienopyrrolyl and furanopyrrolyl compounds and their use as histamine h4 receptor ligands
06/22/2005EP1543003A2 Imidazo[1,2-a]pyridines
06/22/2005EP1542980A1 5-aryltetrazole compounds, compositions thereof, and uses therefor
06/22/2005EP1542978A1 Novel bio-active molecules
06/22/2005EP1542973A1 2,4-substituted indoles and their use as 5-ht6 modulators
06/22/2005EP1542972A2 Cyclooxygenase- 2 selective inhibitors, compositions and methods of use
06/22/2005EP1542966A1 Aromatic liver x-receptor modulators
06/22/2005EP1542948A2 Novel biphenyl and biphenyl-like cannabinoids
06/22/2005EP1542724A2 Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof
06/22/2005EP1542719A2 Methods and compositions for control of bone formation via modulation of sympathetic tone
06/22/2005EP1542716A1 Growth hormone releasing peptides
06/22/2005EP1542710A1 Methods for preserving organs and tissues
06/22/2005EP1542698A2 Modulation of matrix metalloproteinase (mmp) activity with aldosterone blocker(s)
06/22/2005EP1542686A2 Aryl substituted hydantoin compounds and their use as sodium channel blockers
06/22/2005EP1542671A1 Composition based on triethyl citrate for the treatment of bacterial infections of the skin
06/22/2005EP1469856A4 8-heteroaryl xanthine adenosine a sb 2b /sb receptor antagonists
06/22/2005EP1381611B1 Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
06/22/2005EP1372656B1 Pyrazolo[4,3-d]pyrimidinone compounds as cgmp pde inhibitors
06/22/2005EP1320523B1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
06/22/2005EP1244693B1 Compositions for treating abnormalities in glomerular filtration, patent ductus arteriosus and osteoporosis
06/22/2005EP1233964B1 New use and novel n-azabicyclo-amide derivatives
06/22/2005EP1196188B1 Vgf selective monoclonal antibodies and their use for treating vgf-related disorders
06/22/2005EP1177200B1 Ligands for metabotropic glutamate receptors
06/22/2005EP1171136B1 Immunomodulating compositions comprising urea derivatives for use in the treatment of inflammatory diseases
06/22/2005EP1150717B1 Sustained release salts of pharmaceutically active peptides and their production
06/22/2005EP1140273B1 Device for locally delivering a drug in a body cavity
06/22/2005EP1100763B1 Diketoacid-derivatives as inhibitors of polymerases
06/22/2005EP1100542B1 Peg-urate oxidase conjugates and use thereof
06/22/2005EP1082127B1 Succinamide inhibitors of interleukin-1beta converting enzyme
06/22/2005EP1073465B1 T cell inhibitory receptor compositions and uses thereof
06/22/2005EP1040111B1 Integrin receptor antagonists
06/22/2005EP1009411B1 Treatment of sleep apnea
06/22/2005EP0892644B1 In vivo gene transfer methods for wound healing
06/22/2005CN1630730A Methods for detecting and treating the early onset of aging-related conditions
06/22/2005CN1630724A Compositions and methods for inhibiting expression of a target gene
06/22/2005CN1630716A Hematopoietic cells from human embryonic stem cells
06/22/2005CN1630709A Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
06/22/2005CN1630664A Caspase-8 binding protein, its preparation and use
06/22/2005CN1630657A Deazapurines and uses thereof
06/22/2005CN1630656A Dihydropyrazolopyridine compounds and pharmaceutical use thereof
06/22/2005CN1630651A Novel gamma secretase inhibitors
06/22/2005CN1630650A Nitrogenous heterocyclic compound and medicine thereof
06/22/2005CN1630648A N－苯基－2－嘧啶胺衍生物 N- phenyl-2-pyrimidine-amine derivative
06/22/2005CN1630645A 5-HT receptor ligands and uses thereof
06/22/2005CN1630642A Benzenesulfonamide derivatives
06/22/2005CN1630641A Farnesyl protein transferase inhibitors as antitumor agents
06/22/2005CN1630639A Novel pyridine- and quinoline-derivatives
06/22/2005CN1630638A Aryl ureas as kinase inhibitors
06/22/2005CN1630637A Novel arylheteroalkylamine derivatives
06/22/2005CN1630636A Indoline derivatives and their use as 5-HT2 receptor ligands
06/22/2005CN1630635A Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these
06/22/2005CN1630632A Aromatic amino acid derivates and medicinal compositions
06/22/2005CN1630539A Multiple compartment bag assembly for dialysis fluid
06/22/2005CN1630535A Inhibition of STAT-1
06/22/2005CN1630533A Remedy for hypertension
06/22/2005CN1630529A B-cell lymphoma specific antigen for use in diagnosis and treatment of B-cell malignancies
06/22/2005CN1630528A Brain cell or nerve cell protecting agents comprising ginseng
06/22/2005CN1630521A Oral compositions and methods for prevention, reduction and treatment of radiation injury
06/22/2005CN1630517A CXCR4-antagonistic drugs composed of nitrogen-containing compound
06/22/2005CN1630515A Compounds active at the glucocorticoid receptor II
06/22/2005CN1630514A Methods and compositions for control of bone formation via modulation of sympathetic tone
06/22/2005CN1630512A Pharmaceutical tablet
06/22/2005CN1630511A Particulate compositions of eletriptan showing a sigmoidal pattern of controlled release
06/22/2005CN1630510A Atorvastatin calcium in a pharmaceutical form, composition thereof, and pharmaceutical formulation comprising atorvastatin calcium
06/22/2005CN1629156A Pyrudyl and pyrimidylpiperazine derivatives, preparation method thereof and pharmaceutical composition containing the derivatives
06/22/2005CN1629145A Condensed heteroaryl derivatives
06/22/2005CN1628857A Follicular granulosa cell anti-senescence technology
06/22/2005CN1628831A Freeze dried powder injection of dandehon herb and its preparation process
06/22/2005CN1628757A Externally applied healthy medicinal formulation
06/22/2005CN1628743A Anti-fatigue healthy product and its processing method
06/22/2005CN1628704A Anti aging health caring medicine
06/22/2005CN1628703A Method for extracting propolis effective component under high pressure
06/22/2005CN1628693A Glossy ganoderma preparation containing main active substance of glossy ganoderma herb and preparing method thereof
06/22/2005CN1628652A Method for treating palmar fascia and plantar aponeurosis fibromatosis
06/22/2005CN1628561A Combination for releasing lassitude and its preparation method and uses
06/22/2005CN1207298C Triazolopurine derivatives, drug compositions containing the same and adenosine A3 receptor affinitive agents
06/22/2005CN1207297C Crystalline therapeutic agent
06/22/2005CN1207294C Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors
06/22/2005CN1207289C Metalloproteinase inhibitors, pharmaceutical compositions containing the same and their pharmaceutical uses, and methods and intermediates useful for their preparation
06/22/2005CN1207288C Retroviral protease inhibiting compounds
06/22/2005CN1207268C Novel derivatives of 3-3-diphenylpropylamines
1 ... 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 ... 1564